AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
EPS for AVEO Oncology (AVEO)
EPS in 2022 (TTM): -$0.84
According to AVEO Oncology 's latest financial reports the company's current EPS (TTM) is -$0.84. In 2021 the company made an earnings per share (EPS) of -$1.72 a decrease over its 2020 EPS that were of -$1.71.
EPS history for AVEO Oncology from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$0.84 | -51.16% |
| 2021 | -$1.72 | 0.58% |
| 2020 | -$1.71 | -375.81% |
| 2019 | $0.62 | -224% |
| 2018 | -$0.50 | -91.8% |
| 2017 | -$6.10 | 52.5% |
| 2016 | -$4.00 | |
| 2014 | -$10.20 | |
| 2012 | -$26.30 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $5.43 | -746.34% | 🇺🇸 USA |
 Amgen AMGN | $14.15 | -1,784.52% | 🇺🇸 USA |
 Biogen BIIB | $18.46 | -2,297.62% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $37.36 | -4,547.62% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $3.97 | -572.62% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | -$0.11 | -86.90% | 🇺🇸 USA |